Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors

Arthritis Rheum. 1998 Jan;41(1):58-67. doi: 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G.

Abstract

Objective: To determine the overall prevalence of spondylarthropathy (SpA) among whites.

Methods: To screen for SpA symptoms, such as inflammatory back pain (IBP), joint swelling, psoriasis, and uveitis, or a specific family history, questionnaires were mailed to 348 blood donors (174 HLA-B27 positive and 174 HLA-B27 negative). From the responding 273 persons (78%; 140 B27 positive, 133 B27 negative), 126 were selected for further evaluation based on the symptoms reported. Of this group, 90 persons agreed to undergo physical examination (71.4%; 46 B27 positive, 44 B27 negative). There was no difference between the B27-positive and -negative groups in terms of age (mean +/- SD 38.4 +/- 10 versus 39.5 +/- 11 years) and sex ratio (67% versus 68% were men). In addition, 58 donors (32 B27 positive, 26 B27 negative) agreed to undergo magnetic resonance imaging (MRI) of the sacroiliac joints. A diagnosis of SpA and ankylosing spondylitis (AS) was made according to the European Spondylarthropathy Study Group criteria and the New York criteria.

Results: SpA was diagnosed in 20 persons: 19 of 140 B27-positive (13.6%) and 1 of 133 B27-negative (0.7%) subjects (15 male and 5 female). AS was diagnosed in 9 persons (7 male and 2 female; 45%), undifferentiated SpA (USpA) in 7 (5 male and 2 female; 35%), psoriatic arthritis (PsA) in 3 (2 male and 1 female; 15%), and chronic reactive arthritis (ReA; Reiter's syndrome) in 1 (male; 5%). On the basis of a B27 frequency of 9.3% among the population of Berlin (3.47 million persons), the estimated prevalence of SpA was 1.9%, AS was 0.86%, USpA was 0.67%, and PsA was 0.29%. The relative risk of developing SpA in B27-positive subjects was calculated as 20.7 (95% confidence interval 4.6-94.2; P = 0.001). Of 58 persons with IBP, sacroiliitis was detected by MRI in 15 of 32 B27-positive (46.9%) and 1 of 26 B27-negative (3.9%) subjects (P = 0.002). Four of these 16 donors did not fulfill diagnostic criteria for SpA.

Conclusion: With a calculated prevalence of 1.9%, spondylarthropathies are among the most frequent rheumatic diseases in the white population. HLA-B27 positive persons carry a 20-fold increased risk of developing SpA. AS and USpA are the most frequent SpA subtypes. Persons with IBP who are B27 positive have a 50% likelihood of having sacroiliitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Berlin / epidemiology
  • Blood Donors*
  • Female
  • HLA-B27 Antigen / blood*
  • Humans
  • Joint Diseases / diagnosis
  • Joint Diseases / epidemiology*
  • Joint Diseases / immunology
  • Magnetic Resonance Imaging
  • Male
  • Medical History Taking
  • Middle Aged
  • Physical Examination
  • Prevalence
  • Prohibitins
  • Rheumatic Diseases / diagnosis
  • Rheumatic Diseases / epidemiology*
  • Rheumatic Diseases / immunology
  • Sacroiliac Joint
  • Spinal Diseases / diagnosis
  • Spinal Diseases / epidemiology*
  • Spinal Diseases / immunology
  • Surveys and Questionnaires
  • White People

Substances

  • HLA-B27 Antigen
  • PHB2 protein, human
  • Prohibitins